TRAT1 and Menkes disease: From these results, we suggest CoO-TRIM controls ion release when injected into dystrophic skeletal muscle, maintains pH-neutrality, and inhibits HA formation while stimulating myofiber regeneration and angiogenesis, thereby reversing the adverse outcomes of MD.